These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 35130792)

  • 21. Expanded Umbilical Cord Mesenchymal Stem Cells (UC-MSCs) as a Therapeutic Strategy in Managing Critically Ill COVID-19 Patients: The Case for Compassionate Use.
    Atluri S; Manchikanti L; Hirsch JA
    Pain Physician; 2020 Mar; 23(2):E71-E83. PubMed ID: 32214286
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Addressing the 'hypoxia paradox' in severe COVID-19: literature review and report of four cases treated with erythropoietin analogues.
    Begemann M; Gross O; Wincewicz D; Hardeland R; Daguano Gastaldi V; Vieta E; Weissenborn K; Miskowiak KW; Moerer O; Ehrenreich H
    Mol Med; 2021 Sep; 27(1):120. PubMed ID: 34565332
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hazards of the Cytokine Storm and Cytokine-Targeted Therapy in Patients With COVID-19: Review.
    Quirch M; Lee J; Rehman S
    J Med Internet Res; 2020 Aug; 22(8):e20193. PubMed ID: 32707537
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potential usefulness of pentoxifylline, a non-specific phosphodiesterase inhibitor with anti-inflammatory, anti-thrombotic, antioxidant, and anti-fibrogenic properties, in the treatment of SARS-CoV-2.
    González-Pacheco H; Amezcua-Guerra LM; Sandoval J; Arias-Mendoza A
    Eur Rev Med Pharmacol Sci; 2020 Jul; 24(13):7494-7496. PubMed ID: 32706089
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SARS-CoV-2, which induces COVID-19, causes kawasaki-like disease in children: role of pro-inflammatory and anti-inflammatory cytokines.
    Ronconi G; Teté G; Kritas SK; Gallenga CE; Caraffa Al; Ross R; Conti P
    J Biol Regul Homeost Agents; 2020 May-June,; 34(3):767-773. PubMed ID: 32476380
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Kallikrein-kinin blockade in patients with COVID-19 to prevent acute respiratory distress syndrome.
    van de Veerdonk FL; Netea MG; van Deuren M; van der Meer JW; de Mast Q; Brüggemann RJ; van der Hoeven H
    Elife; 2020 Apr; 9():. PubMed ID: 32338605
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HACE2-Exosome-Based Nano-Bait for Concurrent SARS-CoV-2 Trapping and Antioxidant Therapy.
    Ma X; Guo S; Ruan S; Liu Y; Zang J; Yang Y; Dong H; Li Y; Ren T; An M; Li Y
    ACS Appl Mater Interfaces; 2022 Feb; 14(4):4882-4891. PubMed ID: 35067058
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An overview of possible pivotal mechanisms of Genistein as a potential phytochemical against SARS-CoV-2 infection: A hypothesis.
    Jafari A; Esmaeilzadeh Z; Khezri MR; Ghasemnejad-Berenji H; Pashapour S; Sadeghpour S; Ghasemnejad-Berenji M
    J Food Biochem; 2022 Oct; 46(10):e14345. PubMed ID: 35866873
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SARS-CoV-2 and other coronaviruses negatively influence mitochondrial quality control: beneficial effects of melatonin.
    Mehrzadi S; Karimi MY; Fatemi A; Reiter RJ; Hosseinzadeh A
    Pharmacol Ther; 2021 Aug; 224():107825. PubMed ID: 33662449
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A small molecule compound berberine as an orally active therapeutic candidate against COVID-19 and SARS: A computational and mechanistic study.
    Wang ZZ; Li K; Maskey AR; Huang W; Toutov AA; Yang N; Srivastava K; Geliebter J; Tiwari R; Miao M; Li XM
    FASEB J; 2021 Apr; 35(4):e21360. PubMed ID: 33749932
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Can Natural Polyphenols Help in Reducing Cytokine Storm in COVID-19 Patients?
    Giovinazzo G; Gerardi C; Uberti-Foppa C; Lopalco L
    Molecules; 2020 Dec; 25(24):. PubMed ID: 33322757
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A raising dawn of pentoxifylline in management of inflammatory disorders in Covid-19.
    Mostafa-Hedeab G; Al-Kuraishy HM; Al-Gareeb AI; Jeandet P; Saad HM; Batiha GE
    Inflammopharmacology; 2022 Jun; 30(3):799-809. PubMed ID: 35486310
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Melatonin is a potential adjuvant to improve clinical outcomes in individuals with obesity and diabetes with coexistence of Covid-19.
    El-Missiry MA; El-Missiry ZMA; Othman AI
    Eur J Pharmacol; 2020 Sep; 882():173329. PubMed ID: 32615182
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Repurposing of chlorpromazine in COVID-19 treatment: the reCoVery study].
    Plaze M; Attali D; Petit AC; Blatzer M; Simon-Loriere E; Vinckier F; Cachia A; Chrétien F; Gaillard R
    Encephale; 2020 Jun; 46(3S):S35-S39. PubMed ID: 32387014
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potential Immunotherapeutic Targets for Hypoxia Due to COVI-Flu.
    Leyfman Y; Erick TK; Reddy SS; Galwankar S; Nanayakkara PWB; Di Somma S; Sharma P; Stawicki SP; Chaudry IH
    Shock; 2020 Oct; 54(4):438-450. PubMed ID: 32649367
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Niclosamide for Covid-19: bridging the gap.
    Al-Kuraishy HM; Al-Gareeb AI; Alzahrani KJ; Alexiou A; Batiha GE
    Mol Biol Rep; 2021 Dec; 48(12):8195-8202. PubMed ID: 34664162
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The potential of BEN815 as an anti-inflammatory, antiviral and antioxidant agent for the treatment of COVID-19.
    Shin JA; Oh S; Jeong JM
    Phytomed Plus; 2021 Nov; 1(4):100058. PubMed ID: 35403084
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diacerein: A potential multi-target therapeutic drug for COVID-19.
    de Oliveira PG; Termini L; Durigon EL; Lepique AP; Sposito AC; Boccardo E
    Med Hypotheses; 2020 Nov; 144():109920. PubMed ID: 32534337
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypothesis: Alpha-1-antitrypsin is a promising treatment option for COVID-19.
    Bai X; Hippensteel J; Leavitt A; Maloney JP; Beckham D; Garcia C; Li Q; Freed BM; Ordway D; Sandhaus RA; Chan ED
    Med Hypotheses; 2021 Jan; 146():110394. PubMed ID: 33239231
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.
    Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G
    J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.